Both in Biotechnology
X4 Pharmaceuticals vs Agenus
Over the past year XFOR returned −18.4% and AGEN returned +86.9%; their daily moves had a correlation of 0.13.
XFOR −18.4% AGEN +86.9%Growth of $1, one year, split-adjusted
| Metric | XFOR | AGEN |
|---|---|---|
| Price | $3.24 | $6.97 |
| Market cap | $321.2M | $314.8M |
| Today | +2.21% | +4.50% |
| 1 month | +17.0% | −6.9% |
| 6 months | −26.0% | +79.2% |
| Year to date | −19.0% | +122.0% |
| 1 year | −20.8% | +75.6% |
| Revenue growth (YoY) | +346.3% | +34.4% |
| Gross margin | 81.6% | 100.0% |
| Net margin | −183.5% | −1.7% |
| P/E (TTM) | — | 3.4× |
| Price / sales | 20.3× | 2.4× |
| Net cash | $131.2M | -$11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 88.9% |
| Short % of float | 9.3% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).